Sort
23,748 grants matching “melanoma”
EASTERN COOPERATIVE ONCOLOGY GROUP
$266,049Indiana Univ-Purdue Univ At Indianapolis · U10 · FY2003 · CA
REPRESSION BY C SKI AND MELANOMA PROGRESION
$266,026Baylor College Of Medicine · R01 · FY2000 · CA
Applications of the Stereoretentive O and C Rearrangemen
$265,842Colorado State University-Fort Collins · R01 · FY2002 · GM
IDENTIFICATION OF CD8+ T CELL TARGETS ON RENAL CANCER
$265,755Johns Hopkins University · R01 · FY2000 · CA
Identify and amplify T cell effector mechanisms
$265,745Providence Portland Medical Center · R01 · FY2004 · CA
Identify and amplify T cell effector mechanisms
$265,745Providence Portland Medical Center · R01 · FY2003 · CA
Identify and amplify T cell effector mechanisms
$265,745Providence Portland Medical Center · R01 · FY2001 · CA
Identify and amplify T cell effector mechanisms
$265,745Providence Portland Medical Center · R01 · FY2002 · CA
MOLECULAR ASPECTS OF ANTITUMOR ANTIBODIES
$265,725Rockefeller University · R01 · FY2001 · CA
MECHANISMS OF DIETARY MODULATION OF MELANOMA INVASION
$265,663Washington State University · R01 · FY2001 · CA
Project 3: Combining Radiotherapy and Nanotechnology for Immunotherapy
$265,644Andrew Zhuang Wang · Univ Of North Carolina Chapel Hill · U54 · FY2016 · CA
Automated Platform for Fixed Tissue Microdissection
$265,643Stanislav Karsten · Neuroindx Inc. · R44 · FY2016 · CA
Prevention of skin cancer by green tea polyphenols
$265,607Santosh Kumar Katiyar · University Of Alabama At Birmingham · R01 · FY2007 · AT
Novel anti-melanoma agents and their mechanism of action
$265,567Harish C Joshi · Emory University · R01 · FY2006 · CA
Role of NIK Activation in Melanoma Progression
$265,567Ann Richmond · Vanderbilt University · R01 · FY2006 · CA
CYTOTOXIC MECHANISMS IN CUTANEOUS DISEASE
$265,555University Of Colorado Denver · R01 · FY2001 · AR
NCI Patterns of Care (POC)/Quality of Care Study: Diagnosis Years 2017(NSCLC) and 2018 (NSCLC and Melanoma)
$265,538Eric Durbin · University Of Kentucky · N01 · FY2019 · CA
Phase 2 Study of Anti Vegf Antibody in Melanoma
$265,500Ohio State University · R21 · FY2002 · CA
WUSM CANCER AND LEUKEMIA GROUP B
$265,433Washington University · U10 · FY2002 · CA
Surgery and the Mechanisms of Lymph Node Metastases in Cutaneous Melanoma
$265,430Richard Essner · University Of California Los Angeles · R01 · FY2011 · CA
Role of Wnt Signaling in melanoma differentiation and the "stemness" of melanoma
$265,411Ashani Weeraratna · National Institute On Aging · Z01 · FY2008 · AG
Development of therapeutic chemokine-based formulations
$265,411Arya Biragyn · National Institute On Aging · Z01 · FY2008 · AG
MECHANISMS OF IL-2 IMMUNE ENHANCEMENT IN HUMANS
$265,401Mount Sinai School Of Medicine Of Nyu · R01 · FY2000 · AI
Therapy of Melanoma with Bortezomib and Interferon-alpha
$265,363William E. Carson · Ohio State University · R21 · FY2006 · CA
Dendritic Cell Strategies to Tumor Reactive T Cells
$265,245University Of Pittsburgh At Pittsburgh · R01 · FY2004 · CA